ReviewFrontiers in public health2025
Lessons learned from redesigning public health medicines supply chain model in Uttar Pradesh, India.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uttar Pradesh (UP), the most populous state of India with 238 million people, has over 30,000 public health facilities. Ensuring the continuous availability of essential medicines across these facilities is a significant challenge. An audit conducted in 2017 indicated large gaps in the availability of essential medicines in public health facilities. This study describes the lessons from Tamil Nadu's Medical Supplies Corporation (TNMSC) that were adapted to inform the redesign of the medicines supply chain model and processes of Uttar Pradesh's Medical Supplies Corporation (UPMSC). We identified seven essential pillars for a successful public health supply chain system through a desk review and learnings from TNMSC. These included a stable list of essential medicines, warehouses, centralized procurement, a passbook system, quality control, centralized payment, and digital e-tracking to enable real-time inventory and procurement decisions. The system design established a clear responsibility matrix: UPMSC is responsible for ensuring the availability of all essential medicines in the district warehouses at all times. The facility in-charge is responsible for ensuring the availability of the required drugs at the facility. The facilities are notionally allotted a budget and have complete freedom to pickup medicines from the warehouse, as long as they remain within the budget available. Under these seven essential pillars, several key processes were undertaken to improve vendor participation, reduce vendor dependency, synchronize tenders for all essential drugs, and establish rosters for facilities to pick up drugs from the warehouse. These efforts led to an improvement in the availability of essential medicines from ~40% to ~100%, with an average of 275 medicines out of 287 medicines available per warehouse. Supply orders increased from $58 million to $112 million, and facilities consumption value increased from $38 million to $90 million by April 2024. However, challenges such as last-mile delivery and prompt payment to vendors remain. This paper underscores the importance of system design in the public health supply chain and may be useful for other Indian states and low- and lower-middle-income countries (LMICs) with a similar context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.